Dermatology Drugs Market, Size, Share, Growth, Trends, Insight and Industry Forecast, 2021-2028

SKU: DM1738 | Last Updated On: Oct 04 2021 | No. of Pages: 180 | Available Formats

> Global Dermatology Drugs Market Expected to reach a high CAGR of 9.8% By 2028: DataM Intelligence

Global Dermatology Drugs Market is segmented By Application(Atopic Dermatitis, Psoriasis, Acne, Alopecia, Herpes, Rosacea), By Drug Class(Anti-Infectives, Anti-acne, Calcineurin Inhibitors, Retinoids, Corticosteroids, Other Drug Classes), By End-User(Hospitals, Dermatology Clinics, Cosmetic Centers, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global Dermatology Drugs Market is expected to grow at a CAGR of 9.8% during the forecasting period (2021-2028).

Dermatology is a therapeutic field that deals with the diagnosis, prevention, and treatment of diseases such as skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist, ranging from the autoimmune disorder psoriasis to the very common condition acne vulgaris. There are 900 products in the dermatology pipeline with a disclosed stage of development, but the majority of these drugs are at an early stage of development. About 42% of the pipeline is in the Preclinical stage, while 14% is in the discovery stage.

Global Dermatology Drugs Market Dynamics

The global dermatology drugs market growth is driven by rising prevalence of dermatological disorders, strong pipeline of dermatological drugs, and growing awareness about skin diseases. According to American Academy of Dermatology Association, acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Atopic dermatitis is another major disease affecting up to 25 percent of children and 2 to 3 percent of adult. According to National Center for Biotechnology Information, in 2015, atopic dermatitis was recorded to affect around 20% of infants & children and 3% of adults globally. Hence, with rising prevalence of such skin disorders, the demand for the treatment drugs is increasing, hence driving the growth of the dermatology drugs market globally.

However stringent government regulations and adverse effects by certain therapeutic drugs restrain the dermatology drugs market growth. The growing development of innovative products and increasing mergers & acquisitions by key players are expected to provide various opportunities for the market growth during the forecast period.

Global Dermatology Drugs Market Segment Analysis

By application, the dermatology drugs market is segmented into Atopic Dermatitis, Psoriasis, Acne, Alopecia, Herpes, Rosacea, and Others. Among all, Psoriasis is the growing segment with a significant market share with several approved biologics. Psoriasis affects approximately 8 million patients in the U.S. and roughly 20-30% have moderate to severe psoriasis. Out of them, only 10% of the moderate to severe patients are treated with biologics.

Acne is also a common skin condition in the United States, affecting up to 50 million Americans annually. According to American academy of Dermatology, approximately 85% of people between the ages of 12 and 24 experience at least minor acne. Acne can occur at any stage of life and may continue into one’s 30s and 40s. Acne occurring in adults is increasing, affecting up to 15 percent of women. In 2013, the costs associated with the treatment and lost productivity among those who sought medical care for acne exceeded $1.2 billion. More than 5.1 million people sought medical treatment for acne in 2013, primarily children and young adults. There are still unmet needs in the Dermatology drugs market for acne treatment as current treatment options do not offer improved safety, efficacy and tolerability profile often with low patient compliance. Hence, the dermatology drugs market is growing with rising research and development for the treatment of skin diseases.

 

Global Dermatology Drugs Market Geographical Analysis

North America is dominating the global Dermatology Drugs market in 2018 and estimated to hold largest market size over the forecast period (2020-2027) owing to the rising healthcare expenditure, growing awareness about various skin diseases, and presence of large number of pharmaceutical companies are driving the growth of the market in North America. For instance, in 2016, Asthma and Allergy Foundation of America (AAFA) led a three-part national study about atopic dermatitis (AD) in partnership with the National Eczema Association (NEA) and with support from Sanofi Genzyme and Regeneron. According to the study, the AD occurs in 7.3% of adults in the U.S. Of those affected with the disease, about 40% have moderate or severe symptoms. Also, Plaque psoriasis affects approx. 7.5 million Americans with potent topical corticosteroids prescribed to approximately 80% of psoriasis patients diagnosed.. In February 2019, Mayne Pharma Group Limited launched LEXETTE™ (halobetasol propionate) Foam 0.05% in the United States. LEXETTE is part of the US$600m potent topical corticosteroid market for which 8 million prescriptions are written annually.

The Dermatology Drugs market is a highly competitive with new players entering the market and rising approvals of new drugs in the market.  Some of the major players include Bausch Health Companies Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Johnson & Johnson, Allergan plc, Merck & Co. Inc., Amgen Inc., AbbVie Inc, LEO Pharma, among others.

The key players are adopting various key strategies such as product launches, collaborations, mergers & acquisitions which are contributing to the growth of the Dermatology Drugs market globally. For instance,

In June 2019, Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced the U.S. launch of DUOBRII™ (halobetasol propionate and tazarotene) Lotion, 0.01%/0.045%. Approved by the U.S. Food and Drug Administration on April 25, 2019, DUOBRII is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation.

In April 2019, AbbVie, a research-based global biopharmaceutical company, received US FDA approval for SKYRIZI™ (risankizumab-rzaa), an interleukin-23 (IL-23) inhibitor, for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

In March 2019, Schweiger Dermatology Group acquired Dermatology & Skin Surgery Center, with locations in Exton, Coatesville and Kennett Square, PA. Dermatology & Skin Surgery Center.

In February 2019, Evolus, Inc. received the U.S. FDA approval for its lead product, Jeuveau™, for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and procerus muscle activity in adults.

In October 2018, Bausch Health has won tentative approval for a plaque psoriasis lotion that the company sees as key for both turning around its dermatology business and for driving long-term growth

Why Purchase the Report?

  • Visualize the composition of the dermatology drugs in terms of various types of drugs and their applications highlighting the key commercial assets and players.
  • Identify commercial opportunities in dermatology drugs market by analyzing trends and co-development deals. 
  • Excel data sheet with thousands of data points of dermatology drugs market-level 4/5 segmentation.
  • A PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

Target Audience

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers   

 

Table of Contents

  1. Global Dermatology Drugs Market Methodology and Scope

    1. Research Methodology

    2. Research Objective and Scope of the Report

  2. Global Dermatology Drugs Market – Market Definition and Overview

  3. Global Dermatology Drugs Market – Executive Summary

    1. Market Snippet by Product

  4. Global Dermatology Drugs Market – Market Dynamics

    1. Market Impacting Factors

      1. Drivers

        1. Rise in Incidence of Skin diseases

        2. Increasing regulatory approval for Dermatology Drugs

        3. Increasing investment for R&D activities

      2. Restraints

        1. Patent expiry and generic drug development

        2. Side-effects of certain therapeutic drugs

      3. Opportunity

      4. Impact Analysis

  5. Global Dermatology Drugs Market – Industry Analysis

    1. Porter's Five Forces Analysis

    2. Regulatory Analysis

    3. Supply Chain Analysis

    4. Pricing Analysis

  6. Global Dermatology Drugs Market – By Application

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment

      2. Market Attractiveness Index, By Application Segment

    2. Atopic Dermatitis*

        1. Introduction

        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028

    3. Psoriasis

    4. Acne

    5. Alopecia

    6. Herpes

    7. Rosacea

    8. Others

  7. Global Dermatology Drugs Market – By Drug Class

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class Segment

      2. Market Attractiveness Index, By Drug Class Segment

    2. Anti-Infectives*

        1. Introduction

        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028

    3. Anti-acne

    4. Calcineurin Inhibitors

    5. Retinoids

    6. Corticosteroids

    7. Other Drug Classes

  8. Global Dermatology Drugs Market – By End-User

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment

      2. Market Attractiveness Index, By End-User Segment

    2. Hospitals*

        1. Introduction

        2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028

    3. Dermatology Clinics

    4. Cosmetic Centers

    5. Others

  9. Global Dermatology Drugs Market – By Region

    1. Introduction

      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

      2. Market Attractiveness Index, By Region

    2. North America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. U.S.

        2. Canada

        3. Mexico

    3. Europe

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Germany

        2. U.K.

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

    4. South America

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. Brazil

        2. Argentina

        3. Rest of South America

    5. Asia Pacific

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

      6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China

        2. India

        3. Japan

        4. Australia

        5. Rest of Asia Pacific

    6. Middle East and Africa

      1. Introduction

      2. Key Region-Specific Dynamics

      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Class

      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application

      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

  10. Global Dermatology Drugs Market – Competitive Landscape

    1. Competitive Scenario

    2. Market Positioning/Share Analysis

    3. Mergers and Acquisitions Analysis

  11. Company Profiles

    1. LEO Pharma*

      1. Company Overview

      2. Product Portfolio and Description

      3. Key Highlights

      4. Financial Overview

    2. Allergan Inc.

    3. Amgen Inc.

    4. GI Dermatics

    5. Sanofi

    6. Merck & Co.

    7. Pfizer

    8. AbbVie

    9. Medicis Pharmaceutical Corp. (Bausch Health)

    10. Novartis

  12. Global Dermatology Drugs Market – Premium Insights

  13. Global Dermatology Drugs Market – DataM

    1. Appendix

    2. About Us and Services

    3. Contact Us

List of Tables And Figures

List of Tables

Table 1 Global Dermatology Drugs Market Value, By Drug Class, 2018, 2022 & 2028 ($ Million)

Table 2 Global Dermatology Drugs Market Value, By Application, 2018, 2022 & 2028 ($ Million)

Table 3 Global Dermatology Drugs Market Value, By End-User, 2018, 2022 & 2028 ($ Million)

Table 4 Global Dermatology Drugs Market Value, By Region, 2018, 2022 & 2028 ($ Million)

Table 5 Global Dermatology Drugs Market Value, By Drug Class, 2018, 2022 & 2028 ($ Million)

Table 6 Global Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 7 Global Dermatology Drugs Market Value, By Application, 2018, 2022 & 2028 ($ Million)

Table 8 Global Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 9 Global Dermatology Drugs Market Value, By End-User, 2018, 2022 & 2028 ($ Million)

Table 10 Global Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 11 Global Dermatology Drugs Market Value, By Region, 2018, 2022 & 2028 ($ Million)

Table 12 Global Dermatology Drugs Market Value, By Region, 2017-2028 ($ Million)

Table 13 North America Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 14 North America Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 15 North America Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 16 North America Dermatology Drugs Market Value, By Country, 2017-2028 ($ Million)

Table 17 South America Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 18 South America Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 19 South America Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 20 South America Dermatology Drugs Market Value, By Country, 2017-2028 ($ Million)

Table 21 Europe Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 22 Europe Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 23 Europe Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 24 Europe Dermatology Drugs Market Value, By Country, 2017-2028 ($ Million)

Table 25 Asia-Pacific Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 26 Asia-Pacific Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 27 Asia-Pacific Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 28 Asia-Pacific Dermatology Drugs Market Value, By Country, 2017-2028 ($ Million)

Table 29 Middle East & Africa Dermatology Drugs Market Value, By Drug Class, 2017-2028 ($ Million)

Table 30 Middle East & Africa Dermatology Drugs Market Value, By Application, 2017-2028 ($ Million)

Table 31 Middle East & Africa Dermatology Drugs Market Value, By End-User, 2017-2028 ($ Million)

Table 32 Allergan Inc.: Overview

Table 33 Allergan Inc.: Product Portfolio

Table 34 Allergan Inc.: Key Developments

Table 35 Amgen Inc.: Overview

Table 36 Amgen Inc.: Product Portfolio

Table 37 Amgen Inc.: Key Developments

Table 38 GI Dermatics: Overview

Table 39 GI Dermatics: Product Portfolio

Table 40 GI Dermatics: Key Developments

Table 41 LEO Pharma: Overview

Table 42 LEO Pharma: Product Portfolio

Table 43 LEO Pharma: Key Developments

Table 44 Sanofi: Overview

Table 45 Sanofi: Product Portfolio

Table 46 Sanofi: Key Developments

Table 47 Merck & Co.: Overview

Table 48 Merck & Co.: Product Portfolio

Table 49 Merck & Co.: Key Developments

Table 50 Pfizer: Overview

Table 51 Pfizer: Product Portfolio

Table 52 Pfizer: Key Developments

Table 53 AbbVie : Overview

Table 54 AbbVie : Product Portfolio

Table 55 AbbVie : Key Developments

Table 56 Medicis Pharmaceutical Corp. (Bausch Health): Overview

Table 57 Medicis Pharmaceutical Corp. (Bausch Health): Product Portfolio

Table 58 Medicis Pharmaceutical Corp. (Bausch Health): Key Developments

Table 59 Novartis: Overview

Table 60 Novartis: Product Portfolio

Table 61 Novartis: Key Developments

List of Figures

Figure 1 Global Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 2 Global Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 3 Global Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 4 Global Dermatology Drugs Market Share, By Region, 2018 & 2028 (%)

Figure 5 Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 6 Global Dermatology Drugs Market Y-o-Y Growth, By Drug Class, 2018-2028 (%)

Figure 7 Anti-Infectives: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 8 Anti-acne: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 9 Calcineurin Inhibitors: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 10 Retinoids: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 11 Corticosteroids: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 12 Other Drug Classes: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 13 Global Dermatology Drugs Market Y-o-Y Growth, By Application, 2018-2028 (%)

Figure 14 Atopic Dermatitis: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 15 Psoriasis: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 16 Acne: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 17 Alopecia: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 18 Herpes: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 19 Rosacea: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 20 Others: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 21 Global Dermatology Drugs Market Y-o-Y Growth, By End-User, 2018-2028 (%)

Figure 22 Hospitals: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 23 Dermatology Clinics: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 24 Cosmetic Centers: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 25 Others: Global Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 26 Global Dermatology Drugs Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 27 North America Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 28 North America Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 29 North America Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 30 North America Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 31 North America Dermatology Drugs Market Share, By Country, 2018 & 2028 (%)

Figure 32 South America Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 33 South America Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 34 South America Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 35 South America Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 36 South America Dermatology Drugs Market Share, By Country, 2018 & 2028 (%)

Figure 37 Europe Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 38 Europe Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 39 Europe Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 40 Europe Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 41 Europe Dermatology Drugs Market Share, By Country, 2018 & 2028 (%)

Figure 42 Asia-Pacific Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 43 Asia-Pacific Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 44 Asia-Pacific Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 45 Asia-Pacific Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 46 Asia-Pacific Dermatology Drugs Market Share, By Country, 2018 & 2028 (%)

Figure 47 Middle East & Africa Dermatology Drugs Market Value, 2017-2028 ($ Million)

Figure 48 Middle East & Africa Dermatology Drugs Market Share, By Drug Class, 2018 & 2028 (%)

Figure 49 Middle East & Africa Dermatology Drugs Market Share, By Application, 2018 & 2028 (%)

Figure 50 Middle East & Africa Dermatology Drugs Market Share, By End-User, 2018 & 2028 (%)

Figure 51 Allergan Inc.: Financials

Figure 52 Amgen Inc.: Financials

Figure 53 GI Dermatics: Financials

Figure 54 LEO Pharma: Financials

Figure 55 Sanofi: Financials

Figure 56 Merck & Co.: Financials

Figure 57 Pfizer: Financials

Figure 58 AbbVie : Financials

Figure 59 Medicis Pharmaceutical Corp. (Bausch Health): Financials

Figure 60 Novartis: Financials

 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report



Get your free sample proposal with a single click!

linkedinpinterest